V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 250002058 | 250006980 | 1.88 | 70.6 | Curative (C) | 2019-03-22 | 2019-06-13 | null | 02 | N | LIPOSOMAL DOXORUBICIN | 101563165 |
| 250002060 | 250006982 | null | null | Palliative (P) | 2019-02-06 | 2019-02-14 | VIDE | N | N | IRINOTECAN + MDG | 101603681 |
| 250002061 | 250006983 | null | null | Palliative (P) | 2020-09-27 | 2020-10-26 | Trabectedin | 02 | N | TIVOZANIB | 100867497 |
| 250002062 | 250006984 | 1.89 | 126.05 | Palliative (P) | null | 2013-11-23 | Atezolizumab | 02 | Y | ATEZOLIZUMAB | 100922567 |
| 250002065 | 250006985 | null | null | null | 2017-12-13 | 2018-02-27 | null | 02 | null | DOCETAXEL | 101136275 |
| 250002076 | 250006989 | null | 66 | null | 2019-10-28 | 2019-11-07 | null | 02 | null | CARBOPLATIN + PEMETREXED | 100996042 |
| 250002077 | 250006990 | 1.75 | 72.1 | null | 2018-08-28 | 2018-09-23 | Cisplatin + Radiotherapy | 02 | null | TIVOZANIB | 100642313 |
| 250002086 | 250006995 | 1.75 | 53.8 | Palliative (P) | 2020-07-06 | 2020-07-13 | Cabazitaxel | 01 | N | CARBOPLATIN + FLUOROURACIL | 101535464 |
| 250002089 | 250006997 | null | 80 | Palliative (P) | 2021-09-04 | 2021-09-20 | Trial Unspecified | 02 | N | CYCLOPHOSPHAMIDE + TOPOTECAN | 101537663 |
| 250002090 | 250006998 | 1.66 | 106.6 | null | null | 2018-04-13 | Cisplatin + Radiotherapy | null | null | ATEZOLIZUMAB | 101042099 |
| 250002091 | 250006999 | null | null | Palliative (P) | null | 2018-05-01 | Irinotecan + Modified De Gramont | null | null | CARBOPLATIN + FLUOROURACIL | 100337163 |
| 250002100 | 250007004 | 1.69 | 54.5 | null | 2018-05-12 | 2018-05-24 | AVELUMAB + AXITINIB | 02 | N | PAZOPANIB | 100020446 |
| 250002103 | 250007005 | 1.6 | 62.35 | null | 2020-05-19 | 2020-05-19 | PACLITAXEL | 02 | N | PAZOPANIB | 101790789 |
| 250002106 | 250007008 | null | null | Adjuvant (A) | 2018-07-23 | 2018-12-26 | CABOZANTINIB | 02 | N | CARBOPLATIN + PACLITAXEL | 101285689 |
| 250002107 | 250007009 | 1.59 | 100.4 | Palliative (P) | 2019-05-29 | 2019-05-29 | NB HRNBL-1 COJEC Ind COURSE B | 02 | N | BUSULFAN + MELPHALAN | 100626278 |
| 250002110 | 250007010 | 0 | 63 | Palliative (P) | 2018-12-09 | 2018-12-10 | Trial Unspecified | 02 | N | PACLITAXEL | 101112760 |
| 250002111 | 250007011 | 1.8 | 86 | null | null | 2019-05-30 | Cisplatin + Radiotherapy | 02 | N | IPILIMUMAB + NIVOLUMAB | 100056306 |
| 250002113 | 250007012 | 1.69 | 59 | Adjuvant (A) | 2019-09-01 | 2019-09-01 | EW EuroEwing 2012 Arm B CE | 2 | null | RMS 2005 TRIAL | 100126209 |
| 250002114 | 250007013 | 1.84 | 61.4 | Palliative (P) | 2019-08-21 | 2019-08-27 | null | 02 | N | FLUOROURACIL + IRINOTECAN | 100857853 |
| 250002115 | 250007014 | 1.73 | 54.8 | null | null | 2018-11-01 | Mitomycin Intravesical | null | N | CARBOPLATIN + PEMETREXED | 101274992 |
| 250002116 | 250007015 | 1.89 | 66.7 | null | 2020-07-28 | 2020-08-14 | Antibody NBL | 02 | null | TRIAL UNSPECIFIED | 101526348 |
| 250002119 | 250007017 | 1.8 | 46 | Curative (C) | 2018-11-17 | 2018-11-17 | Fluorouracil+Mitomycin+RT (Anal Ca) | 02 | N | NB HRNBL-1 COJEC IND COURSE C | 100796064 |
| 250002120 | 250007018 | null | null | null | 2020-01-06 | 2020-01-07 | Carboplatin + Paclitaxel (3 weekly) | 01 | N | ATEZOLIZUMAB | 101504562 |
| 250002121 | 250007019 | 1.6 | 141 | Palliative (P) | 2017-07-23 | 2017-07-28 | null | 02 | N | ATEZOLIZUMAB | 101421269 |
| 250002125 | 250007021 | 1.67 | 66.8 | Neo-adjuvant (N) | 2020-01-04 | 2020-01-20 | STS Rhabdomyosarcoma RMS 2005 IVA | 02 | N | CABAZITAXEL | 101525975 |
| 250002127 | 250007023 | 1.62 | 77.7 | Neo-adjuvant (N) | 2018-05-09 | 2018-05-30 | Atezolizumab | null | null | CABOZANTINIB | 100332075 |
| 250002129 | 250007024 | null | 66.7 | null | 2019-06-29 | 2019-10-15 | Dinutuximab Beta | 02 | N | DOXORUBICIN | 100892019 |
| 250002131 | 250007026 | 1.64 | 58 | null | 2020-05-07 | 2020-05-26 | null | 02 | N | CISPLATIN + PEMETREXED | 100919250 |
| 250002136 | 250007031 | 1.65 | 66.4 | null | null | 2018-04-02 | null | null | null | GEMCITABINE | 100529938 |
| 250002137 | 250007032 | 1.77 | 70.4 | null | 2020-01-19 | 2020-01-19 | GEMCITABINE + RT | 99 | null | CARBOPLATIN + FLUOROURACIL | 100623950 |
| 250002144 | 250007035 | 1.57 | 74.5 | Neo-adjuvant (N) | null | 2020-05-04 | CETUXIMAB | N | N | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL | 100036514 |
| 250002153 | 250007037 | 1.96 | 57 | null | 2020-05-29 | 2020-06-12 | CYCLOPHOSPHAMIDE + DOXORUBICIN + VINCRISTINE | 02 | N | PAZOPANIB | 100292841 |
| 250002159 | 250007041 | 1.69 | 105 | Curative (C) | 2018-07-22 | 2018-08-15 | Carboplatin + Liposomal Doxorubicin | 02 | N | CABOZANTINIB | 101834052 |
| 250002163 | 250007042 | null | null | Palliative (P) | 2019-01-02 | 2019-01-30 | Trial Unspecified | 02 | null | CETUXIMAB + CISPLATIN + FLUOROURACIL | 101357085 |
| 250002167 | 250007043 | 1.69 | 62.65 | Palliative (P) | 2021-05-11 | 2021-05-11 | Pazopanib | 02 | null | CAPECITABINE + DOCETAXEL | 100377277 |
| 250002168 | 250007044 | null | 87.6 | Neo-adjuvant (N) | 2019-06-06 | 2020-03-06 | null | 02 | N | CARBOPLATIN + PEMETREXED | 100434701 |
| 250002170 | 250007046 | null | null | null | null | 2019-02-03 | CABOZANTINIB | null | null | ENZALUTAMIDE | 100612166 |
| 250002180 | 250007048 | 1.74 | 11.6 | Palliative (P) | 2018-06-27 | 2018-07-09 | Carboplatin AUC 2 - 5 | 02 | null | TIVOZANIB | 101795528 |
| 250002186 | 250007051 | 1.6 | 10.7 | null | 2019-10-14 | 2019-11-01 | CISPLATIN + FLUOROURACIL | 01 | N | CAPECITABINE + OXALIPLATIN | 100759721 |
| 250002189 | 250007053 | 1.6 | 48.2 | Palliative (P) | 2017-06-04 | 2017-06-29 | CARBOPLATIN + PACLITAXEL | 2 | Y | CARBOPLATIN | 100959745 |
| 250002194 | 250007055 | 1.71 | 69.2 | null | 2021-02-19 | 2021-02-28 | null | 02 | N | CARBOPLATIN + CETUXIMAB + FLUOROURACIL | 100325175 |
| 250002195 | 250007056 | 1.77 | 95.1 | Palliative (P) | 2020-06-13 | 2020-06-17 | Paclitaxel 7 day | 02 | N | CARBOPLATIN + PEMBROLIZUMAB + PEMETREXED | 100277141 |
| 250002200 | 250007060 | 1.67 | 132 | Curative (C) | 2019-11-23 | 2020-03-10 | null | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100682583 |
| 250002202 | 250007061 | 0 | 90 | Palliative (P) | null | 2022-03-09 | Capecitabine (21days) + Carboplatin | 01 | null | CARBOPLATIN + PACLITAXEL | 100307271 |
| 250002203 | 250007062 | 1.33 | 91.7 | null | 2018-06-02 | 2018-09-25 | AFATINIB | 02 | null | CARBOPLATIN + FLUOROURACIL | 100082985 |
| 250002209 | 250007064 | 1.68 | 74.5 | Palliative (P) | null | 2021-06-03 | null | 02 | N | DOXORUBICIN | 100917404 |
| 250002212 | 250007065 | null | null | null | null | 2019-07-12 | Atezolizumab | null | null | CARBOPLATIN + PEMETREXED | 100197493 |
| 250002222 | 250007067 | 1.69 | 88 | Palliative (P) | 2016-12-24 | 2016-12-24 | null | 02 | null | CARBOPLATIN + PEMETREXED | 100512772 |
| 250002223 | 250007068 | 1.67 | 61.1 | Curative (C) | 2018-01-02 | 2018-03-16 | null | 02 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101307704 |
| 250002233 | 250007071 | null | null | Adjuvant (A) | 2019-01-11 | 2019-05-02 | null | 02 | null | DOXORUBICIN | 101668607 |